Depression disease management system based on targeted metabolomics and machine learning model

WO2026118650A1PCT designated stage Publication Date: 2026-06-11NANJING LIKANG PHARMACEUTICAL TECHNOLOGY CO LTD

Patent Information

Authority / Receiving Office
WO · WO
Patent Type
Applications
Current Assignee / Owner
NANJING LIKANG PHARMACEUTICAL TECHNOLOGY CO LTD
Filing Date
2025-09-28
Publication Date
2026-06-11

Smart Images

  • Figure CN2025125047_11062026_PF_FP_ABST
    Figure CN2025125047_11062026_PF_FP_ABST
Patent Text Reader

Abstract

A depression disease management system based on targeted metabolomics and a machine learning model, characterized by comprising: an intelligent diagnosis model module, a differential diagnosis model module, a graded diagnosis model module, a companion diagnosis model module, a treatment endpoint outcome prediction model module, a recurrence prediction model module, and a comprehensive determining module. The system provided by the present invention can solve existing difficulties in the fields of clinical diagnoses, treatment outcome, and recurrence of depression, achieve accurate diagnoses and timely treatment, and improve the mental health level of the whole people.
Need to check novelty before this filing date? Find Prior Art